Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
<1 3-<5
General Information
Revision date
2013-11-25
Product name
PAXIL TABLETS
Product Synonyms
AROXAT 20 MG TABLETS * DEROXAT 20 MG TABLETS * NDC NO. 0029-3210-13 * NDC NO. 0029-3211-13 * NDC NO. 0029-3211-21 * NDC NO. 0029-3211-59 * NDC NO. 0029-3212-13 * NDC NO. 0029-3213-13 * PAXIL 10 MG TABLETS * PAXIL 20 MG TABLETS * PAXIL 30 MG TABLETS * PAXIL 40 MG TABLETS * AROPAX 20 MG TABLETS * AROPAX 30 MG TABLETS * TAGONIS 20 MG TABLETS * SEROXAT TABLETS * PAXIL DC * PAROXETINE HYDROCHLORIDE, FORMULATED PRODUCT
Manufacturer Name
GlaxoSmithKline US
Emergency telephone
+1 703 527 3887
Icons in SDS
Company Information
company name
GlaxoSmithKline US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
Section 2
SECTION 2: Hazards identification
Classified hazards Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device
2.2 Label elements
Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device. Hazard(s) not otherwise classified (HNOC) Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.1 Classification of the substance or mixture
Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
